Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
02/28/2008 | US20080050824 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use |
02/28/2008 | US20080050823 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use |
02/28/2008 | US20080050822 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use |
02/28/2008 | US20080050820 Casein kinase stress-related polypeptides and methods of use in plants |
02/28/2008 | US20080050819 Constructs for Marker Excision Based on Dual-Function Selection Marker |
02/28/2008 | US20080050818 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use |
02/28/2008 | US20080050811 Testicular carnitine transporter and its gene |
02/28/2008 | US20080050810 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49 |
02/28/2008 | US20080050809 Novel human kinases and polynucleotides encoding the same |
02/28/2008 | US20080050807 Gene encoding alkaline liquefying alpha-amylase |
02/28/2008 | US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture |
02/28/2008 | US20080050791 Pufa polyketide synthase systems and uses thereof |
02/28/2008 | US20080050790 Pufa polyketide synthase systems and uses thereof |
02/28/2008 | US20080050776 Stable mutated pro nerve growth factors |
02/28/2008 | US20080050774 Computer-based system for monitoring differential expression; host cells |
02/28/2008 | US20080050759 Screening Assay for Anti-Bacterial Compounds |
02/28/2008 | US20080050758 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer detection |
02/28/2008 | US20080050745 Sugar chain synthesizing agent having beta1,3-N-acetyglucosaminyltransferase activity |
02/28/2008 | US20080050742 Methods and Reagents for Combined PCR Amplification |
02/28/2008 | US20080050741 Messenger RNA Profiling: Body Fluid Identification Using Multiplex Reverse Transcription-Polymerase Chain Reaction (RT-PCR) |
02/28/2008 | US20080050738 Detection of target nucleic acid |
02/28/2008 | US20080050728 suppressing non-specific cross-hybridization between repetitive elements present in nucleic acid probes and corresponding repetitive elements in the target nucleic acid by using DNA synthesized to contain a plurality of repetitive elements while avoiding low and single copy sequences |
02/28/2008 | US20080050726 Methods for diagnosing pancreatic cancer |
02/28/2008 | US20080050718 Methods, Articles, and Compositions for Identifying Oligonucleotides |
02/28/2008 | US20080050505 Phosphopantetheinyl transferases from bacteria |
02/28/2008 | US20080050460 Uses of lectin-conotoxin |
02/28/2008 | US20080050406 Modified Dermatophagoides pteronyssinus allergen Der p 5 protein which inhibits immunoglobulin E (IgE) binding when exposed again to the antigen; treating allergies |
02/28/2008 | US20080050402 comprising replacements in the influenza nonstructural 1 (NS1) polypeptide, that interferes with viral replication and phosphatidylinositol 3-kinase activation, used for treating and preventing influenza virus infection |
02/28/2008 | US20080050396 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits |
02/28/2008 | US20080050393 Novel nucleic acids and polypeptides |
02/28/2008 | US20080050386 Novel proteins, gene encoding the same and method of utilization thereof |
02/28/2008 | US20080050376 Compositions And Uses Thereof For Identifying And Targeting Provasopressin-Expressing Cancer Cells |
02/28/2008 | US20080050363 Novel nucleic acid molecules encoding opioid growth factor receptors |
02/28/2008 | US20080050358 Identification of Snps Associated with Hyperlipidemia, Dyslipidemia and Defective Carbohydrate Metabolism |
02/28/2008 | US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder |
02/28/2008 | US20080050345 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same |
02/28/2008 | US20080050310 Antibodies and immunoconjugates and uses therefor |
02/28/2008 | CA2661765A1 Antisense composition and method for inhibition of mirna biogenesis |
02/28/2008 | CA2661292A1 Compositions and methods for treating myelosuppression |
02/28/2008 | CA2643356A1 Synthetic genomes |
02/27/2008 | EP1892299A2 Sense mRNA therapy |
02/27/2008 | EP1892298A1 Streptococcal C5a peptidase vaccine |
02/27/2008 | EP1891438A2 Methods for identifying ligands for stem cells and cells derived therefrom |
02/27/2008 | EP1891238A2 Method for breast cancer diagnosis/prognosis |
02/27/2008 | EP1890711A1 Compounds for treating or preventing amine oxidase related diseases or disorders |
02/27/2008 | EP1890708A1 Glucose inducible insulin expression and methods of treating diabetes |
02/27/2008 | EP1789578A4 Cleavable solid phases for isolating nucleic acids |
02/27/2008 | EP1587412A4 Methods of detecting gene expression in normal and cancerous cells |
02/27/2008 | EP1567540A4 Cftr allele detection assays |
02/27/2008 | EP1141278B1 Therapeutic pde4d phosphodiesterase inhibitors |
02/27/2008 | EP0739350B1 Ligand that binds fas antigen |
02/27/2008 | CN101133166A Making nucleic acid sequences in parallel and use |
02/27/2008 | CN101133074A RNAi modulation of APOB and uses thereof |
02/27/2008 | CN101133073A Synthesis of oligonucleotides |
02/27/2008 | CN101130784A Method for altering plant flower organ morphology and its special expression vector |
02/27/2008 | CN101130776A Pig carcass character GFAT1 gene clone and its application |
02/27/2008 | CN101130774A Nucleotide molecule SR5B and its application in preparation of antidiabetic medicine |
02/27/2008 | CN101130773A Nucleotide molecule SR5B2 and its application in preparation of antidiabetic medicine |
02/27/2008 | CN101130772A Nucleotide molecule SR4B2 and its application in preparation of antidiabetic medicine |
02/27/2008 | CN101130771A Nucleotide molecule SR3B2 and application of the same in producing antidiabetic medicament |
02/27/2008 | CN101130770A Nucleotide molecule SR2B and application of the same in producing antidiabetic medicament |
02/27/2008 | CN101130769A Nucleotide molecule SR4B and application of the same in producing antidiabetic medicament |
02/27/2008 | CN101130768A Nucleotide molecule SR1B and application of the same in producing antidiabetic medicament |
02/27/2008 | CN101130762A Efficient bacillus thuringiensis cry8H gene, protein for vaginata destructive insect and uses of the same |
02/27/2008 | CN101130565A Nucleotide molecule SR3B and application of the same in producing antidiabetic medicament |
02/27/2008 | CN101130564A Nucleotide molecule SR2B2 and application of the same in producing antidiabetic medicament |
02/27/2008 | CN101130563A Nucleotide molecule SR1B2 and application of the same in producing antidiabetic medicament |
02/27/2008 | CN100371444C VEGF expression-inhibiting siRNA and application thereof |
02/27/2008 | CN100371441C Vectors and methods for tissue specific synthesis of protein in eggs of transgenic hens |
02/27/2008 | CN100371343C Molecule marking method for discriminating cytoplasmic male sterile gene of leaf mustard |
02/27/2008 | CN100371342C Foot and mouth disease virus infectious complementary deoxyribonucleic acid and its preparation method |
02/26/2008 | US7335813 Comprising transcription regulating nucleotide sequences with guard cell-preferential or guard cell-specific expression profiles in plants obtainable from Arabidopsis thaliana gene At5g58580, or from Arabidopsis genomic DNA sequences as described in patent |
02/26/2008 | US7335765 Nucleoside and oligonucleotide analogues |
02/26/2008 | US7335764 12 to 30 nucleobases in length targeted to a nucleic acid molecule encoding acyl CoA cholesterol acyltransferase-2 that hybridizes with and inhibits the expression; treating atherosclerosis, cardiovascular disorders or metabolism disorders |
02/26/2008 | US7335763 A ribozyme-resistant cell for producing a HSV expression vector encoding an anti-HSV ribozyme; comprising at least one nucleotide sequence encoding a portion of an HSV gene, having been modified to not be cleavable by ribozyme; Hammerhead ribozymes |
02/26/2008 | US7335762 Cuvette for use in the concurrent monitoring, recording and analysis of lignt emission in microarrays |
02/26/2008 | US7335761 Expression vector comprising regulatory sequences associated with tissue specific expression of ovomucoid gene for use as a gene expression control elements in heterologous gene transfer and transcription in birds |
02/26/2008 | US7335759 Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides |
02/26/2008 | US7335757 Carbonyl reductase, gene encoding the same, and process for producing optically active alcohols using the same |
02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
02/26/2008 | US7335755 Nucleic acids isolated in neuroblastoma |
02/26/2008 | US7335754 Ehrlichia canis genes and vaccines |
02/26/2008 | US7335750 Hybrid compositions for intracellular targeting |
02/26/2008 | US7335748 RG1 antibodies and uses thereof |
02/26/2008 | US7335746 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
02/26/2008 | US7335745 Vectors with DNA encoding pro polypeptides |
02/26/2008 | US7335740 Monoclonal antibody for use in diagnosis, treatment and prevention of cell proliferative, inflammatory, nervous system and immunological disorders |
02/26/2008 | US7335738 Heregulin-like factor |
02/26/2008 | US7335735 Intracellular estradiol binding protein (IEBP) for use as tool in identifying modulator for treatment and prevention of bone and cell proliferative disorders |
02/26/2008 | US7335732 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
02/26/2008 | US7335731 PRO4332 polypeptides |
02/26/2008 | US7335730 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
02/26/2008 | US7335729 PRO4320 polypeptide |
02/26/2008 | US7335647 Drugs for liver diseases |
02/26/2008 | US7335506 Trangenic methylobacillus which has enhanced production of lysine and arginine for use in medicine, animal feeds and cosmetics |
02/26/2008 | US7335504 Engineered enzymes and uses thereof |
02/26/2008 | US7335503 Fermentation medium comprising a granular starch hydrolyzing enzyme having glucoamylase activity (GSHE) produced from a culture of Trichoderma reesei |
02/26/2008 | US7335502 Protein comprising an amino acid sequence having a chlorohydrin and hydroxycarboxylic ester asymmetric hydrolase activity; stereoselectivity ; can produce an optically active compound with an industrial scale by using microorganisms with the gene |
02/26/2008 | US7335501 Derived from fungi of the Penicillium genus; vectors and transformed host organisms containing these polynucleotides encoding the phytases |
02/26/2008 | US7335499 tRNA synthetase |